FDA chief: Transparency, commitment key to regaining public trust

10/14/2009 | CNNMoney/Fortune

The FDA is undertaking initiatives to make its decision-making process more transparent as a means to regaining public trust and confidence in the agency, FDA Commissioner Margaret Hamburg said in an interview. The agency also needs to develop a more streamlined regulatory process for drugs and other medical products to include the application of biomarkers and test-animal models, Hamburg said.

View Full Article in:

CNNMoney/Fortune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA